Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| COVID-19 ärevuse skaala× | COVID-19 vaimse tervise mõju skaala× | |
|---|---|---|
| Valdkond | Rahvatervis | Rahvatervis |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta | 2020 | 2020 |
| Looja≠ | Lipp et al. | Wang et al. |
| Tüüp | Self-report | Self-report |
| Algallikas≠ | Lipp, A., Fazio, S., & Cohen, S. (2020). COVID-19 anxiety in the United States. International Journal of Mental Health and Addiction, 20(3), 1234–1248. link ↗ | Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., Ho, C. S., & Ho, R. C. (2020). Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) pandemic among the general population in China. International Journal of Environmental Research and Public Health, 17(5), 1729. DOI ↗ |
| Rööpnimetused | CAS | CMHIS |
| Seotud | 3 | 3 |
| Kokkuvõte≠ | The COVID-19 Anxiety Scale (CAS) is a brief, self-administered instrument designed to assess anxiety symptoms specifically related to the COVID-19 pandemic. Developed by Lipp and colleagues in 2020, it captures worry about infection, social isolation, and pandemic-related uncertainties. The scale is widely used in epidemiological surveys and clinical research to identify individuals experiencing pandemic-related anxiety requiring intervention. | The COVID-19 Mental Health Impact Scale (CMHIS) is a brief, multidimensional instrument assessing anxiety, depression, and stress symptoms triggered by the COVID-19 pandemic. Developed by Wang and colleagues in 2020 during the initial pandemic wave in China, it captures the spectrum of psychological distress across multiple symptom domains. The CMHIS has been widely adopted in pandemic surveillance and mental health research across 30+ countries, providing rapid assessment of population mental health burden. |
| ScholarGateAndmestik ↗ |
|
|